Event-Driven Stocks

ALX ONCOLOGY HOLDINGS INC

ALXONasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 1 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue———$0$0$1.2M
Operating income−$104.0M−$142.5M−$170.3M−$127.4M−$83.6M−$43.7M
Net income−$101.7M−$134.8M−$160.8M−$123.5M−$83.5M−$45.7M
Total assets$59.0M$147.8M$242.6M$306.5M$380.2M$436.1M
Total liabilities$33.1M$34.2M$52.8M$43.0M$17.1M$6.2M
Equity$26.0M$113.6M$189.7M$263.5M$363.0M$429.8M
EPS (diluted)$-1.90$-2.58$-3.74$-3.03$-2.07$-2.76
Shares out.53.4M50.2M40.9M40.6M40.1M39.8M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
—
Net margin
—
Return on equity
−391.4%
Return on assets
−172.2%
Return on capital (ROCE)
−301.6%
Liabilities / assets
56.0%
Debt / equity
1.27×
Book value / share
$0.49
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-48.01distress
Accruals / assets
−29.7%clean
Piotroski F-Score
1/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
61
/ 100
Profitability 0Growth n/aCatalyst 100Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 1 warning● 1 good
  • Altman Z″ in the distress zone
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
1 acquisitions4 disposals1 open-market buy(s)net +3.2M shares · last 5
InsiderDateTypeSharesPrice
Lettmann JasonOfficer — CHIEF EXECUTIVE OFFICERMar 19, 2026Sell12,311$2.17
Pinto ShellyOfficer — SVP, FINANCE AND CAOMar 19, 2026Sell903$2.17
Pinto ShellyOfficer — SVP, FINANCE AND CAOFeb 18, 2026Sell565$2.27
Lettmann JasonOfficer — CHIEF EXECUTIVE OFFICERFeb 17, 2026Tax withholding2,201$2.27
Goodman Corey SDirectorFeb 2, 2026Buy3.2M$1.57

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.4M1.9-37.5%
Apr 30, 20262.2M1.9+7.9%
Apr 15, 20262.0M1.7-8.0%
Mar 31, 20262.2M2.9+81.7%
Mar 13, 20261.2M2.4+4.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)